10x Genomics Commercially Launches Xenium Platform for In Situ Analysis
/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first...
Source: prnewswire.com